1 / 7

Immuno-Oncology Assays Market Growth in Future Scope 2023-2030

The global immuno-oncology assays market was valued at US$ 3,718.5 Mn in 2021 and is forecast to reach a value of US$ 7,594.6 Mn by 2028 at a CAGR of 10.7% between 2022 and 2028. Immuno-oncology is emerging as a novel approach to cancer treatment through the stimulation of the body's own immune system. <br>Sample Link: https://www.coherentmarketinsights.com/insight/request-sample/2632 <br><br><br>

Saya10
Download Presentation

Immuno-Oncology Assays Market Growth in Future Scope 2023-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immuno-Oncology Assays Market 2023 Market Size 2023 US$ 3,718.5 Mn 2030 Value Projection US$ 7,594.6 Mn CAGR 10.7%

  2. Global Immuno-Oncology Assays Market Definition • The global immuno-oncology assays market was valued at US$ 3,718.5 Mn in 2022 and is forecast to reach a value of US$ 7,594.6 Mn by 2030 at a CAGR of 10.7% between 2023 and 2030. • Immuno-oncology is emerging as a novel approach to cancer treatment through the stimulation of the body's own immune system. It is a formidable weapon against cancer as it has the ability to harness the body's natural defenses against infection. It is method that tap into the patient's own immune system to detect and destroy cancer cells. Immuno-oncology is one of the most promising areas of research in the world of anti-cancer therapeutics. • Click Here: https://www.coherentmarketinsights.com/insight/request-sample/2632

  3. Segments covered: By Application By Technology By Product: Consumables Software Clinical Diagnostics Research and Development Immunoassay PCR NGS Flow Cytometry Others

  4. Immuno-Oncology Assays Marketb Competitive Analysis • Charles River • Roche • Llumina • Agilent Technologies, Inc.

  5. Immuno-Oncology Assays Market – Growth Drivers, Restraints & Challenges Growth Drivers Restraints & Challenges Dearth of skilled professionals Unfavourable regulatory and reimbursement scenario • Rise in burden of cancer across the globe • Increase in focus on the development of novel cancer treatments

  6. Key features of the study: • This report provides in-depth analysis of the global immuno-oncology assays market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2021 as the base year. • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players. • It profiles key players in the global immuno-oncology assays market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

  7. CONTACT US

More Related